French company DNA Script will contribute its enzymatic DNA synthesis technologies, while Quantoom of Belgium will bring its ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui as its Chair Designate. Dr. Slaoui, a notable figure ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a ...

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi) ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities ...

If you're looking to dig into the world of hi-fi systems that consist of a separate stereo receiver or integrated amplifier that powers a set of passive speakers — whether your passion is ...

NANOdesign is a specialized tool for designing and optimizing LNPs for mRNA vaccines. Nanostructures can be formed by artificial design or by natural self-assembly mechanisms, which rely on ...

Solo wilderness survival skills training pushes individuals into scenarios that necessitate rapid, critical thinking and decision-making. Tasks such as locating shelter, procuring water, or even ...

Three months after I was diagnosed, I heard about Cameron Boyce’s passing of Sudden Unexpected Dead in Epilepsy (SUDEP). My doctor did not tell me this was a possibility, and it caused me to spiral.

Wall Street is off to a volatile start in 2025, with investors stepping on the sell pedal after last week's jobs data, followed by a sharp about-face in sentiment following Wednesday's consumer ...